WatchGov

119th Congress

H.R. 2343

John W. Walsh Alpha-1 Home Infusion Act of 2025

  1. Introduced
  2. In committee
  3. Passed House
  4. Passed Senate
  5. To President
  6. Became law
Sponsor
Maria Elvira Salazar(R-FL)
Introduced
Mar 25, 2025
Policy area
Health
Committees
House Committee on Energy and Commerce; House Committee on Ways and Means
Official text
Introduced in House · Congress.gov page

Cosponsors (60)

Original cosponsors (8)

Added later (52)

Summary

Summary by the Congressional Research Service· describes the “Introduced in House” version

John W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Roll-call votes

No recorded votes on this bill.

Actions